Artal Group’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $271K | Sell |
|
|||||
|
2024
Q1 | $445K | Hold |
|
|||||
|
2023
Q4 | $466K | Hold |
|
|||||
|
2023
Q3 | $475K | Hold |
|
|||||
|
2023
Q2 | $572K | Sell |
|
|||||
|
2023
Q1 | $1.21M | Hold |
|
|||||
|
2022
Q4 | $1.82M | Hold |
|
|||||
|
2022
Q3 | $2.39M | Hold |
|
|||||
|
2022
Q2 | $1.52M | Hold |
|
|||||
|
2022
Q1 | $3.08M | Hold |
|
|||||
|
2021
Q4 | $4.78M | Hold |
|
|||||
|
2021
Q3 | $8.53M | Hold |
|
|||||
|
2021
Q2 | $10.8M | Buy |
|
|||||
|
2021
Q1 | $5.07M | Hold |
|
|||||
|
2020
Q4 | $5.56M | Hold |
|
|||||
|
2020
Q3 | $11.1M | Sell |
|
|||||
|
2020
Q2 | $10.9M | Sell |
|
|||||
|
2020
Q1 | $4.93M | Buy |
|
|||||
|
2019
Q4 | $3.7M | Hold |
|
|||||
|
2019
Q3 | $16.5M | Hold |
|
|||||
|
2019
Q2 | $15.6M | Buy |
|